DavidSRubensteinMD
Dermatology • Chapel Hill, NCProfessor, Dermatology, University of North Carolina at Chapel Hill School of Medicine
Dr. Rubenstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 919-966-4996Fax+1 919-843-5515
Education & Training
University of North Carolina HospitalsResidency, Dermatology, 1994 - 1997
University of MichiganInternship, Internal Medicine, 1993 - 1994
Duke University School of MedicineClass of 1993
Certifications & Licensure
NC State Medical License 1994 - 2025- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Use of KC706 for the Treatment of Pemphigus Vulgaris Start of enrollment: 2007 Nov 01
Publications & Presentations
PubMed
- Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children.Eric L Simpson, Adelaide A Hebert, John Browning, Rocco T Serrao, Howard Sofen
Dermatology and Therapy. 2025-01-07 - 7 citationsTapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivot...Jonathan I Silverberg, Lawrence F Eichenfield, Adelaide A Hebert, Eric L Simpson, Linda Stein Gold
Journal of the American Academy of Dermatology. 2024-09-01 - 2 citationsRapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis.Leon Kircik, Matthew Zirwas, Shawn G Kwatra, G Michael Lewitt, Holly Glover
Dermatology and Therapy. 2024-01-01
Press Mentions
Ramaswamy Loses Another Key Exec as Fouse Jumps Ship to AgiosSeptember 5th, 2018
Grant Support
- Adhesion Junction Regulation In Normal And Diseased SkinNational Institute Of Allergy And Infectious Diseases2001–2011
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
